4
Changes in Ownership
Coherus Oncology, Inc. Filed Acc 0001209191-14-067902
Chief Scientific Officer acquired 239,952 shares (option exercise)
- Chief Scientific Officer acquired 46,718 shares (conversion)
- Chief Scientific Officer disposed of 26,756 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Herman Alan C. · Chief Scientific Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-11-12 | Option exercise : show line 1 in the form | +239,952 | $1.67 | $400,000 | 239,952 | D |
| 2014-11-12 | Other disposition : show line 2 in the form | −26,756 | 213,196 | D | ||
| 2014-11-12 | Conversion : show line 3 in the form | +1,503 | 214,699 | D | ||
| 2014-11-12 | Conversion : show line 4 in the form | +39,991 | 294,940 | I | ||
| 2014-11-12 | Conversion : show line 5 in the form | +5,224 | 300,164 | I |
Table II: Derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-11-12 | Option exercise : show line 6 in the form Warrant to Purchase Common Stock | −239,952 | 0 | D | ||
| 2014-11-12 | Option exercise : show line 7 in the form Warrant to Purchase Series B Preferred Stock | −1,505 | 0 | D | ||
| 2014-11-12 | Option exercise : show line 8 in the form Series B Preferred Stock | +1,505 | $0.02 | $25 | 1,505 | D |
| 2014-11-12 | Other disposition : show line 9 in the form Series B Preferred Stock | −2 | 1,503 | D | ||
| 2014-11-12 | Conversion : show line 10 in the form Series B Preferred Stock | −1,503 | 0 | D | ||
| 2014-11-12 | Conversion : show line 11 in the form Series A Preferred Stock | −39,991 | 0 | I | ||
| 2014-11-12 | Conversion : show line 12 in the form Series B Preferred Stock | −5,224 | 0 | I |
Loading xslF345X03/doc4.xml…